Hims & Hers Health CFO Okupe Oluyemi sold 7,163 shares on 2026-07-06 at an average price of $36.49 per share, for total proceeds of about $261.35K. The sale was reported as being made under a pre-scheduled Rule 10b5-1 trading plan, meaning the timing and amount were set in advance rather than decided day-to-day. Sales by a chief financial officer can draw attention because the CFO typically has deep visibility into a company’s financial performance, cash position, and outlook. That said, 10b5-1 plan transactions are commonly used by executives to diversify holdings or manage personal finances while reducing concerns that trades are based on nonpublic information. As a result, this type of sale is generally viewed as more routine than an open-market sale made at the insider’s discretion. Over the past 30 days, the only disclosed insider activity at HIMS was this single sale by Okupe. With no recent cluster of insider selling or buying in the provided window, the filing reads more like standard planned activity than a broader shift in insider behavior.